Silicon Laboratories (SLAB)
(Delayed Data from NSDQ)
$111.76 USD
-2.61 (-2.28%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $111.84 +0.08 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Income Statements
Fiscal Year end for Silicon Laboratories, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 782 | 1,024 | 721 | 887 | 838 |
Cost Of Goods | 322 | 382 | 295 | 359 | 327 |
Gross Profit | 461 | 643 | 425 | 528 | 510 |
Selling & Adminstrative & Depr. & Amort Expenses | 485 | 523 | 458 | 489 | 454 |
Income After Depreciation & Amortization | -24 | 119 | -33 | 38 | 57 |
Non-Operating Income | 19 | 14 | 6 | 11 | 13 |
Interest Expense | 6 | 7 | 31 | 34 | 20 |
Pretax Income | -11 | 126 | -58 | 15 | 50 |
Income Taxes | 8 | 38 | 13 | 3 | 30 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | -16 | 3 | 14 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -35 | 91 | -58 | 13 | 19 |
Extras & Discontinued Operations | 0 | 0 | 2,175 | 0 | 0 |
Net Income (GAAP) | -35 | 91 | 2,117 | 13 | 19 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 28 | 178 | 52 | 122 | 127 |
Depreciation & Amortization (Cash Flow) | 52 | 59 | 85 | 84 | 70 |
Income After Depreciation & Amortization | -24 | 119 | -33 | 38 | 57 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 31.80 | 36.04 | 44.32 | 44.37 | 44.29 |
Diluted EPS Before Non-Recurring Items | 0.39 | 3.30 | 1.14 | 1.94 | 2.15 |
Diluted Net EPS (GAAP) | -1.09 | 2.54 | 47.78 | 0.28 | 0.43 |
Fiscal Year end for Silicon Laboratories, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 145.37 | 106.38 | 86.84 | 203.76 | 244.87 |
Cost Of Goods | 68.78 | 51.31 | 42.92 | 84.74 | 101.09 |
Gross Profit | 76.58 | 55.07 | 43.93 | 119.03 | 143.78 |
SG&A, R&D, and Dept/Amort Expenses | 124.61 | 114.20 | 117.03 | 106.81 | 126.61 |
Income After SG&A, R&D, and Dept/Amort Expenses | -48.03 | -59.13 | -73.10 | 12.22 | 17.17 |
Non-Operating Income | 2.79 | 2.73 | 3.61 | 2.94 | 7.78 |
Interest Expense | 0.26 | 0.51 | 0.94 | 1.36 | 1.60 |
Pretax Income | -45.49 | -56.91 | -70.44 | 13.80 | 23.35 |
Income Taxes | 36.66 | -0.39 | -15.54 | 3.39 | 12.34 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | -14.88 | -0.06 | -0.06 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -82.16 | -56.53 | -69.79 | 10.35 | 10.96 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -82.16 | -56.53 | -69.79 | 10.35 | 10.96 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 32.12 | 31.91 | 31.85 | 32.08 | 32.93 |
Diluted EPS Before Non-Recurring Items | -1.06 | -1.34 | -1.46 | 0.48 | 0.59 |
Diluted Net EPS (GAAP) | -2.56 | -1.77 | -2.15 | 0.32 | 0.33 |